UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of July 2024
For the month of July 2024
Commission File Number: 001-41641
SHL TELEMEDICINE LTD.
(Translation of registrant’s name into English)
90 Yigal Alon Street
Tel Aviv 67891, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On July 29, 2024, SHL Telemedicine Ltd. (the “Company”) issued a press release, a copy of which is furnished herewith as Exhibit 99.1. In the press release, the Company
announced that it has appointed David Arnon to serve as the Company’s new Chief Executive Officer, effective August 6, 2024. As previously disclosed in the Company’s Form 6-K filed with the Securities and Exchange Commission on March 14, 2024, Erez
Nachtomy, the Company’s current CEO, announced his resignation, which will be effective upon Mr. Arnon assuming the position of CEO.
This Form 6-K is incorporated by reference into the Company's Registration Statement on Form S-8
filed with the Securities and Exchange Commission on June 9, 2023 (Registration No. 333-272546).
| Exhibit | Description |
| 99.1 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
SHL Telemedicine Ltd.
|
|||
|
By:
|
/s/ Amir Hai | ||
| Amir Hai | |||
| Chief Financial Officer | |||
|
July 29, 2024
|
|||